Iterum Therapeutics plc Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
CREATIVE FINANCIAL DESIGNS INC /ADV | 02/10/2025 | 59,900 | $106,023 | 100.00% | 0.30% |
BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC | 02/07/2025 | 66 | $117 | 0.00% | 0.00% |
CYPRESS CAPITAL MANAGEMENT LLC (WY) | 01/23/2025 | 66 | $117 | 0.00% | 0.00% |
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | 01/17/2025 | 13 | $23 | 0.00% | 0.00% |
Iterum Therapeutics plc institutional Ownership - FAQ's
During the previous two years, 13 institutional investors and hedge funds held shares of Iterum Therapeutics plc. The most heavily invested institutionals were:
CREATIVE FINANCIAL DESIGNS INC /ADV: 59,900
Cypress Capital Management LLC (WY): 66
BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC: 66
Nelson, Van Denburg & Campbell Wealth Management Group, LLC: 13
American Portfolios Advisors: 0
QS Investors, LLC: 384,200
0.30% of Iterum Therapeutics plc stock is owned by institutional investors.
Institutional investors have bought a total of 676,974 shares in the last 24 months. This purchase volume represents approximately $1.34 M in transactions.